"Fleishman-Hillard [3] is counseling Roche [4], which now says it is doing everything possible to meet the demand for Tamiflu, according to Michael Rinaldo, head of F-H's health group in New York," O'Dwyer's PR Daily reports. "Roche says it is 'doing everything possible' to meet demand for flu drug." The company's reputation took a hit last month when it appeared to be "more eager to protect its 'monopoly' on its Tamiflu - the vaccine most effective in fighting bird flu - than preventing a worldwide avian flu pandemic," O'Dwyer's writes.